Loading organizations...
eHealth Ventures is a venture capital firm and technological incubator based in Tel Aviv, Israel, that invests in early-stage digital health and deep health tech startups. Operating under an Israel Innovation Authority incubator license, the firm manages $70 million in assets under management and maintains a portfolio of more than eight active companies. The four-person team provides capital, market validation, and product development services, typically participating in early funding rounds with check sizes ranging from $700,000 to $1 million. The organization collaborates with strategic partners such as Maccabi Healthcare Services, Amgen, and the Mayo Clinic to support the commercialization of emerging medical technologies. Recent investment activity includes backing vertical artificial intelligence applications, such as a $700,000 allocation into the medical diagnostics startup EfA. eHealth Ventures was founded around 2017 by managing partner Talor Sax.
Key people at eHealth Ventures.
Key people at eHealth Ventures.
eHealth Ventures has 3 tracked investments across 2 companies. The latest tracked deal is $6.5M Other Equity in EfA Technologies in April 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 11, 2024 | EfA Technologies | $6.5M Other Equity | ARC Impact, EHealth Ventures, Israeli Innovation Authority, Venturing Tech | — |
| Apr 21, 2023 | Identifai-genetics | $3.3M genetics - Seed | EHealth Ventures | RON Sabar |
| Dec 12, 2018 | EfA Technologies | $900K Seed | EHealth Ventures | — |
eHealth Ventures (eHV) is an early-stage venture capital firm specializing in digital health investments, based in Tel Aviv, Israel, with operations in the US.[1][3][4] Its mission centers on optimizing venture building through a unique alliance of strategic healthcare partners and a skilled professional team, providing 360-degree support for clinical integration, business validation, and commercial expansion of portfolio companies.[1][5] The firm's investment philosophy emphasizes innovation in solving complex healthcare challenges, scalability for long-term growth, and impact on patient outcomes and social good, targeting pre-seed, seed, early-stage, and Series A rounds, often as lead or co-investor.[2][3]
With $70 million in assets under management and a portfolio of 34 companies (from reviewing 1,900 over six years), eHV delivers 10x value-add through partners' resources like vast EMR datasets, pilot facilities, and follow-on investment opportunities.[1][3][5] It significantly influences Israel's startup ecosystem by offering "smart money"—combining capital with market access, infrastructure, and expertise to accelerate digital health innovations.[1][6]
eHealth Ventures emerged as a multinational consortium designed to fuel early-stage digital health tech in Israel with strategic backing, evolving into a dedicated fund with a corporate division under eHealth Group.[2][6] While exact founding year details are not specified, the firm has reviewed 1,900 companies over six years, indicating operations since around 2019, and manages the eHealth2030 fund launched with $70 million AUM.[3][5]
Key partners include Stephen M. Shapiro, a US partner with 50 years in leadership at ADP, cellular firms, and digital health, boasting exits over $1 billion and advisory roles at American University; and Sebastian Fainbraun, CFA, a US partner, entrepreneur, and founding partner at Shafa Invesco, serving as venture partner in private equity ventures.[5] The team's multidisciplinary mix of medical leaders, IT entrepreneurs, and financial experts has shifted focus toward comprehensive support from sourcing to liquidity events.[1][5]
eHealth Ventures rides the wave of digital health transformation, capitalizing on AI, wearables, and data-driven tools to address healthcare inefficiencies like diagnostics, workflows, and mobility amid aging populations and post-pandemic telehealth demand.[1][3] Timing is ideal in Israel's "Startup Nation" ecosystem, where digital health startups thrive on strong medtech talent and global export potential, amplified by eHV's local-global bridge.[4][6]
Market forces favoring it include exploding demand for scalable, impactful solutions (e.g., non-invasive devices, AI ops), vast partner data/infrastructure reducing barriers for early-stage firms, and co-investment appeal in a $70M fund amid VC interest in healthtech.[1][2][3] eHV influences the ecosystem by de-risking ventures through validation resources, fostering exits, and promoting innovations that enhance patient care globally.[5]
eHealth Ventures is primed for expansion as digital health matures, potentially growing AUM and portfolio via deeper AI/genomics integrations and international pilots.[3][5] Trends like personalized medicine, regulatory easing for at-home diagnostics, and EMR interoperability will shape its path, boosting scalability for high-impact exits.[1][2] Its influence may evolve toward leading larger rounds or spinning out operator-led accelerators, solidifying its role as a pivotal "smart money" player in global healthtech—optimizing ventures to truly move the needle on lives.[1][5]
